Atlas Trials

PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease

Clinical trial NCT00343954 · UNKNOWN

Trial details

NCT number
NCT00343954
Sponsor
Angiogenix
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Sickle Cell Disease
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.